Cargando…

Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients

Circulating epithelial tumor cells (CETC) are considered to be responsible for the formation of metastases. Therefore, their importance as prognostic and/or predictive markers in breast cancer is being intensively investigated. Here, the reliability of single cell expression analyses in isolated and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mäurer, Matthias, Pachmann, Katharina, Wendt, Thomas, Schott, Dorothea, Wittig, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482075/ https://www.ncbi.nlm.nih.gov/pubmed/34590615 http://dx.doi.org/10.3390/curroncol28050302

Ejemplares similares

Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer
por: Mäurer, Matthias, et al.
Publicado: (2022)

Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer
por: Schott, Dorothea Sonja, et al.
Publicado: (2021)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
por: Pizon, Monika, et al.
Publicado: (2018)

Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors
por: Schott, Dorothea Sonja, et al.
Publicado: (2017)

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
por: Pachmann, Katharina, et al.
Publicado: (2010)

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma
por: Pachmann, Katharina, et al.
Publicado: (2011)

Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients
por: Pizon, Monika, et al.
Publicado: (2013)

The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer
por: Pizon, Monika, et al.
Publicado: (2016)

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients
por: Pizon, Monika, et al.
Publicado: (2022)

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring
por: Pachmann, Katharina, et al.
Publicado: (2005)

Monitoring of circulating epithelial tumor cells using the Maintrac(®) method and its potential benefit for the treatment of patients with colorectal cancer
por: Gold, Madeleine, et al.
Publicado: (2021)

The Value of Monitoring the Behavior of Circulating Tumor Cells at the End of Endocrine Therapy in Breast Cancer Patients
por: Pachmann, Katharina, et al.
Publicado: (2018)

Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(® )is a predictor for relapse: A preliminary report
por: Rolle, Axel, et al.
Publicado: (2005)

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells
por: Camara, Oumar, et al.
Publicado: (2006)

Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer
por: Pizon, M, et al.
Publicado: (2013)

Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography-computed tomography imaging
por: Willecke-Hochmuth, Regina, et al.
Publicado: (2016)

Epithelial Cell Dissemination and Readhesion: Analysis of Factors Contributing to Metastasis Formation in Breast Cancer
por: Hekimian, Katya, et al.
Publicado: (2012)

Tumor Cell Seeding During Surgery—Possible Contribution to Metastasis Formations
por: Katharina, Pachmann
Publicado: (2011)

Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer
por: Inhestern, Johanna, et al.
Publicado: (2015)

Decision regret in breast cancer patients after adjuvant radiotherapy
por: Köksal, Mümtaz, et al.
Publicado: (2023)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Special Techniques of Adjuvant Breast Carcinoma Radiotherapy
por: Kolářová, Iveta, et al.
Publicado: (2022)

Prone versus supine position for adjuvant breast radiotherapy: a prospective study in patients with pendulous breasts
por: Krengli, Marco, et al.
Publicado: (2013)

Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®
por: Troeller, Almut, et al.
Publicado: (2015)

A prospective interventional study investigating sleep disorders prior to and during adjuvant radiotherapy for breast cancer
por: Rades, Dirk, et al.
Publicado: (2021)

Effect of adjuvant radiotherapy in elderly patients with breast cancer
por: Stueber, Tanja Nadine, et al.
Publicado: (2020)

Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
por: Cho, Won Kyung, et al.
Publicado: (2019)

High depletion of breast cancer cells from the peripheral blood with the method of non-specific separation
por: Payer, Petra, et al.
Publicado: (2020)

Radiotherapy in the Adjuvant and Advanced Setting of CSCC
por: Muto, Paolo, et al.
Publicado: (2021)

Role of Adjuvant Radiotherapy in Gastric Cancer
por: Yu, Jeong Il
Publicado: (2023)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
por: Chang, Jee Suk, et al.
Publicado: (2013)

Expression level of epithelial cell adhesion molecule (EpCAM) of circulating tumor cells (CTCs) of patients with NSCLC as an early indicator to monitor the effects of postoperative adjuvant chemotherapy
por: Zhen, De Zhi, et al.
Publicado: (2021)

The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
por: Abbas, Hamza, et al.
Publicado: (2011)

Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases
por: Le Scodan, Romuald, et al.
Publicado: (2010)

Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer
por: Flores-Balcázar, Christian H, et al.
Publicado: (2018)

Risk of coronary stenosis after adjuvant radiotherapy for breast cancer
por: Wennstig, A.-K., et al.
Publicado: (2022)

Postoperative Adjuvant Radiotherapy for Patients with Gastric Adenocarcinoma
por: Lim, Do Hoon
Publicado: (2012)

Should Adjuvant Radiotherapy Be Recommended for Pediatric Craniopharyngiomas?
por: Dadlani, Ravi, et al.
Publicado: (2014)

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
por: Komaki, Ritsuko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m8jagv9scpc22slj5km978qi9c